Lifestyle Medical Network (LMNK) 10-Q 15 May 17 2017 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2017	May 15, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	LIFESTYLE MEDICAL NETWORK, INC.
Entity Central Index Key	1,307,140
Trading Symbol	lmnk
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Mar. 31, 2017
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2,017
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		34,885,375

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Mar. 31, 2017	Dec. 31, 2016
CURRENT ASSETS:
Cash and cash equivalents	$ 55,979	$ 48,376
Accounts receivable-related party	19,984	68,360
Accounts receivable	461,497	232,715
Prepaid expenses	281,250	275,034
Total Current Assets	818,710	624,485
Property, plant and equipment - net	70,876	69,902
Prepaid expenses-net of current portion	133,280	200,802
TOTAL ASSETS	1,022,866	895,189
CURRENT LIABILITIES:
Accounts payable and accrued expenses	633,411	426,219
Accounts payable-related party	89,835	71,929
Notes payable	525,000	545,000
Current portion of convertible notes payable, net of $158,594 and $304,718 debt discount	1,331,926	1,185,802
Total Current Liabilities	2,580,172	2,228,950
LONG-TERM LIABILITIES:
Convertible notes payable, net of $2,488 and $4,543 debt discount	47,512	45,457
Total Liabilities	2,627,684	2,274,407
Commitments and Contingencies
STOCKHOLDERS' DEFICIENCY:
Common stock, $.001 par value, 200,000,000 shares authorized; 34,885,375 and 33,958,257 shares issued and outstanding at March 31, 2017 and December 31, 2016, respectively	34,885	33,959
Additional paid-in-capital	10,967,655	10,948,581
Accumulated deficit	(12,607,358)	(12,361,758)
Total Stockholders' Deficiency	(1,604,818)	(1,379,218)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	$ 1,022,866	$ 895,189

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Net of debt discount	$ 158,594	$ 304,718
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	34,885,375	33,958,257
Common stock, shares outstanding	34,885,375	33,958,257
Debt discount- Long term convertible notes payable	$ 2,488	$ 4,543

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Revenues:
Management fees-related party	$ 142,611	$ 180,000
Management fees	1,197,494
Rental income-related party		103,500
Total revenues	1,340,105	283,500
Costs and expenses:
Cost of revenue related to management fees	918,601	133,963
Cost of revenue related to rental income		67,894
Cost of revenue- related party management fees	260,297
Selling, general and administrative expenses	202,025	168,030
Total Costs and expenses	1,380,923	369,887
Loss from operations	(40,818)	(86,387)
Other income (expense):
Other income		25,000
Interest expense	(204,782)	(86,525)
Total Other income (expense)	(204,782)	(61,525)
Loss from operations before provision for income taxes	(245,600)	(147,912)
Provision for income taxes
Net loss	$ (245,600)	$ (147,912)
Loss per common share-basic and diluted	$ (0.01)	$ 0
Weighted average common shares outstanding - basic and diluted	34,062,446	33,658,257

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net loss	$ (245,600)	$ (147,912)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of intangible assets		1,388
Depreciation	7,240	8,687
Amortization of debt discounts	148,179	57,775
Changes in operating assets and liabilities:
Accounts receivable	(228,782)
Accounts receivable-related party	48,376	51,531
Prepaid expenses	81,306	49,188
Accounts payable-related party	17,906
Accounts payable and accrued expenses	207,192	99,159
Net Cash Provided by (Used In) Operating Activities	35,817	119,816
Cash flows from investing activities:
Purchase of equipment	(8,214)
Advances to related party		(181,300)
Net Cash Used In Investing Activities	(8,214)	(181,300)
Cash flows from financing activities:
Proceeds from short-term debt		30,000
Repayments of short-term debt	(20,000)	(6,000)
Net Cash Provided by Financing Activities	(20,000)	24,000
Net change in cash	7,603	(37,484)
Cash and cash equivalents - Beginning of period	48,376	49,719
Cash and cash equivalents - End of period	55,979	12,235
Cash paid for:
Cash paid for interest
Cash paid for income taxes
Non-cash Investing and Financing Activities:
Issuance of warrants for prepaid services	20,000
Cashless conversion of warrants	$ 926

Description of Business and Sum

Description of Business and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2017
Description of Business and Summary of Significant Accounting Policies [Abstract]
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The consolidated balance sheet as of March 31, 2017 and the consolidated statements of operations, stockholders' deficiency and cash flows for the periods presented have been prepared by Lifestyle Medical Network Inc. and Subsidiaries (the "Company" or "Lifestyle") and are unaudited. The consolidated financial statements are prepared in accordance with the requirements for unaudited interim periods, and consequently, do not include all disclosures required to be made in conformity with accounting principles generally accepted in the United States of America. In the opinion of management, all adjustments (consisting solely of normal recurring adjustments) necessary to present fairly the financial position, results of operations, changes in stockholders' deficiency and cash flows for all periods presented have been made. The information for the consolidated balance sheet as of December 31, 2016 was derived from audited financial statements of the Company. Organization Lifestyle Medical Network Inc. and Subsidiaries (the “Company” or “Lifestyle”) was incorporated in the State of Nevada. The Company directs its operations through its subsidiaries. The Company, through its consulting subsidiaries, plans to continue to identify and enter into management and professional consulting services agreements, and to license medical and health technologies, to medical and health clinic operating companies. The Company also intends to open, operate and acquire medical and health clinics, if financing is available and the profile of the clinics’ is favorable. Current Operations As of the date of this report, the Company is focusing its efforts, through our consulting subsidiaries, Lifestyle Texas Medical Management LLC and Lifestyle Florida Medical Management LLC, on providing administrative support and practice management services to healthcare providers. In May 2016, the Company commenced working with Global Physicians Healthcare, Inc. (“Global”), of which the Company’s Chief Executive Officer, Christopher Smith, and another Director, each own a one-third equity interest. The Company entered into a support services agreement with Global in September 2016, under which Global has provided valuable assistance to the Company as a marketing and services consultant in marketing services to healthcare providers and healthcare systems. The Company following initiation of its healthcare provider support services in 2016 is now expanding its generated marketing efforts for client healthcare providers. The Company’s services package is tailored to a practice group’s specific needs. Practices can select from menu of business solutions including billing, HR/PEO, accounting and consulting, computer technical support, compliance, and administrative functions including, but not limited to, equipment selection, budgeting, and staffing recruitment. The Company has access to a nationwide network of ancillary providers of local and regional medical practice solutions. As a result, the Company’s client medical practices may benefit from cost savings, higher quality of patient care, and increased productivity efficiencies and revenue. The Company is continuing to look for opportunities in the direct ownership of clinics where the operations of the clinic would be compatible with the applicable regulatory regime governing ownership of medical practices and where the clinic’s operations would complement the Company’s current practice management services operations. Going Concern The consolidated financial statements for the three months ended March 31, 2017 have been prepared on a going concern basis which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. The Company has a past history of recurring losses from operations. The Company will require additional funding to execute its future strategic business plan. Successful business operations and its transition to attaining profitability are dependent upon obtaining additional financing and achieving a level of revenue to support its cost structure. These factors raise substantial doubt about the Company's ability to continue as a going concern. The Company had entered into Management agreements with six medical clinics in Houston, Texas. The Company terminated its agreements as of December 31, 2016. Through the Company’s consulting subsidiaries, the Company is currently providing administration support and practice management services to healthcare providers. Management believes these services will be profitable and the cash flows from these operations will enable the Company to fund the operations of the consolidated group over the next twelve months. Therefore, the annual financial statements continue to be prepared on a going concern basis. Significant Accounting Policies The Company’s significant accounting policies are found below. These policies should be read in conjunction with Note 1 found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016. There were no significant changes to these accounting policies during the three months ended March 31, 2017 and the Company does not expect that the adoption of other recent accounting pronouncements will have a material impact on its financial statements. Principles of Consolidation The consolidated financial statements of the Company include the Company and its wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated. Revenue Recognition The Company records revenue from management fees for providing administrative support and practice management services in accordance with management agreements to other healthcare providers. The Company receives an agreed percentage of the net revenues of these healthcare providers once cash is collected. At this point the services have been rendered, price is determinable and collectability is assured. Use of Estimates The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires the Company to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates including, but not limited to, those related to such items as income tax exposures, accruals, depreciable/useful lives, allowance for doubtful accounts and valuation allowances. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.

Property and Equipment

Property and Equipment	3 Months Ended
	Mar. 31, 2017
Property and Equipment [Abstract]
PROPERTY AND EQUIPMENT	2. PROPERTY AND EQUIPMENT Property and equipment consists of the following: March 31, December 31, 2017 2016 Equipment $ 124,101 $ 115,887 Accumulated depreciation (53,225 ) (45,985 ) $ 70,876 $ 69,902 Depreciation expense for three months ended March 31, 2017 and 2016 was $7,240 and $8,687, respectively.

Debt

Debt	3 Months Ended
	Mar. 31, 2017
Debt [Abstract]
DEBT	3. DEBT Short-term debt as of March 31, 2017 and December 31, 2016 were as follows: March 31, December 31, 2017 2016 Short-term and Convertible Debt Unsecured promissory note, interest 12% per annum, due July 15, 2017 $ 150,000 $ 150,000 Unsecured promissory note, interest 10%, due August 15, 2017 75,000 75,000 Convertible promissory note, interest 10% per annum, due November 1, 2017 100,000 100,000 Convertible promissory note, interest 12% per annum, due April 28, 2017 and June 8, 2017 (2) 562,565 461,897 Convertible promissory note, interest 12% per annum, due December 17, 2016 100,000 100,000 Convertible promissory note, interest 10% per annum, due November 1, 2017 50,000 50,000 Unsecured promissory note, interest 10% per annum, due May 1, 2017 25,000 25,000 Secured promissory note, interest 6% per anum due October 15, 2017 (6) 275,000 275,000 Convertible promissory note, interest 12% per annum, due June 13, 2017 (3) 246,685 242,652 Unsecured promissory note, interest free, due on demand (1) - 20,000 Convertible promissory note, interest 12% per annum, due June 13, 2017 (4) 206,874 187,467 Convertible promissory note, interest 12% per annum, due November 28, 2017 (5) 65,802 43,786 Convertible promissory note, interest 12% per annum, due August 24, 2018 (7) 47,512 45,457 1,904,438 1,776,259 Less: Current portion 1,856,926 1,730,802 $ 47,512 $ 45,457 (1) On February 18, 2016, the Company executed an unsecured promissory note with Gail Keats (an unrelated party) and received $30,000. The promissory note is interest-free and is payable on or before August 15, 2016. The Company repaid the note in full in July 2016. In October 2016, Keats advanced an additional $20,000. The note is interest free and due on demand. The Company repaid the note in full in March 2017. (2) On May 16, 2016, the Company amended its loan agreements with Roy Meadows (“Meadows”), an unrelated party. The Company agreed to pay Meadows a renewal fee of $28,000 and $27,956 on its two outstanding loans with Meadows and extend the maturity dates of the loans to April 28, 2017 and June 8, 2017, respectively. The new outstanding balances of the loans including interest and the renewal fees amounted to $308,000 and $307,520, respectively. The Company also agreed to amend the conversion price of the loans into the Company’s common stock to $0.10 per share. At any time, the holder of the notes, at his option, shall have the right to convert the outstanding principal balance or any portion of the principal amount hereof, and any accrued interest into shares of common stock of the Company. The fair value of the common stock at the date of issuance of the advance was $0.13, which created a Beneficial Conversion Feature of $409,766, the beneficial conversion feature was recorded as a debt discount over the life of the notes. The debt discount as of March 31, 2017 was $52,955. (3) On June 13, 2016, the Company issued a convertible promissory note to Meadows and received proceeds of $250,000.The promissory note bears interest 12% per annum and matures one year from the date of issuance. At any time, the holder of the note, at his sole option, shall have the right to convert the outstanding principal amount of this note, or any portion of the principal hereof, and any accrued interest into shares of common stock of the Company, at a conversion price of $0.15 per share. The fair value at the date of issuance was $0.07, which created a beneficial conversion feature of $16,355, the beneficial conversion feature was recorded as a debt discount over the life of the debt. The debt discount as of March 31, 2017 was $3,315. (4) On October 17, 2016, the Company issued a convertible note to Meadows and received proceeds of $250,000. The promissory note bears interest 12% per anum and matures on June 13, 2017. At any time, the holder of the note, at his sole option, shall have the right to convert the outstanding principal amount of this note, or any portion hereof, and any accrued interest into shares of common stock of the Company, at a conversion price of $0.06 per share. The fair value of the common stock at the date of issuance of the advance was $0.07, which created a beneficial conversion feature of $78,705, the beneficial conversion feature was recorded as a debt discount over the life of the note. The debt discount as of March 31, 2017 was $43,126. (5) On November 28, 2016, the Company issued a convertible note to Meadows and received proceeds of $125,000. The promissory note bears interest 12% per anum and matures on November 28, 2017. At any time, the holder of the note, at his sole option, shall have the right to convert the outstanding principal amount of this note, or any portion hereof, and any accrued interest into shares of common stock of the Company, at a conversion price of $0.06 per share. The fair value of the common stock at the date of issuance of the advance was $0.15, which created a beneficial conversion feature of $89,286, the beneficial conversion feature was recorded as a debt discount over the life of the note. The debt discount as of March 31, 2017 was $59,198. (6) On April 1, 2016, the Company issued a secured promissory note to Emile Fares, M.D. (the “Payee”), an unrelated party, and promised to the Payee $275,000 in exchange for all the medical equipment owned by RMC Totalcare Medical PA. The secured promissory note bears interest 6% per anum and matures one year from the date issuance. On April 1, 2017, the Company and payee entered into an agreement to modify the original note of the Company to the payee to decrease the principal amount of the note from $275,000 to $70,000, and to extend the maturity to October 15, 2017. Any interest accrued would be included as part of the principal payment. (7) On August 24, 2016, the Company issued a convertible note to Daniel Hagen, an unrelated party, and received proceeds of $50,000. The promissory note bears interest 10% per anum and matures on August 24, 2018. At any time, the holder of the note, at his sole option, shall have the right to convert the outstanding principal amount of this note, or any portion hereof, and any accrued interest into shares of common stock of the Company, at a conversion price of $0.06 per share. The fair value of the common stock at the date of issuance of the advance was $0.07, which created a beneficial conversion feature of $8,333, the beneficial conversion feature was recorded as a debt discount over the life of the note. The debt discount as of March 31, 2017 was $2,488. Interest expense for the three months ended March 31, 2017 and 2016 amounted to $204,782 and $86,525, respectively.

Accounts Payable and Accrued Ex

Accounts Payable and Accrued Expenses	3 Months Ended
	Mar. 31, 2017
Accounts Payable and Accrued Expenses [Abstract]
ACCOUNTS PAYABLE AND ACCRUED EXPENSES	4 ACCOUNTS PAYABLE AND ACCRUED EXPENSES March 31, December 31, 2017 2016 Interest $ 228,239 $ 171,636 Salaries – Officer - - Professional fees 111,778 104,278 Consulting 281,263 124,384 Other 12,131 25,921 $ 633,411 $ 426,219 Consulting fee – related Party $ 89,835 $ 71,929

Basic and Diluted Earnings Per

Basic and Diluted Earnings Per Share	3 Months Ended
	Mar. 31, 2017
Basic and Diluted Earnings Per Share [Abstract]
BASIC AND DILUTED EARNINGS PER SHARE	5. BASIC AND DILUTED EARNINGS PER SHARE Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net earnings by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At March 31, 2017 there were 36,455,250 potential common shares respectively. Because of the net loss, the effect of these potential common shares is anti-dilutive.

Warrants

Warrants	3 Months Ended
	Mar. 31, 2017
Warrants [Abstract]
WARRANTS	6. WARRANTS In January 2017, the Company issued warrants to the directors of the Company to purchase 200,000 shares of common stock at an exercise price of $0.09 per share. The warrants were issued in connection with services to be provided through December 31, 2017. These warrants vest immediately and expire 5 years from the date of issuance. The fair value of the warrants was $20,000, all of which was expensed during the three months ended March 31, 2017. In March 2017, Roy Meadows exercised a cashless common stock purchase warrant and the Company issued Roy Meadows 927,118 shares of common stock. The remaining balance of the warrant was cancelled. In February 2017, 2,400,000 warrants expired. The estimated value of the warrants was determined using the Black Scholes pricing model using the following assumptions: expected term of 5 years, a risk free interest rate of 1.19%, a dividend yield of -0- and volatility of 387.1%. The fair value of the warrants issued amounted to $20,000. The following table summarizes the changes in warrants outstanding and the related price of the shares of the Company's common stock issued. The warrants were granted in lieu of cash compensation for services performed. Shares Price Life Value Outstanding, January 1, 2017 22,834,564 $ 0.10 4.4 Granted 200,000 0.09 5.0 Expired/Cancelled (2,532,446 ) Exercised (927,118 ) 0.025 Outstanding, March 31, 2017 19,575,000 $ 0.09 4.8 years $ 2,769,500 Exercisable, March 31, 2017 19,575,000 $ 0.09 4.8 years $ 2,769,500

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2017
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	7. RELATED PARTY TRANSACTIONS a) Our Chief Executive Officer, Christopher Smith and Nathan Hawkins, a director of the Company, are each a 33 ½ % owner of Global Physicians Healthcare, Inc. a healthcare consulting company, which was paid $260,297 by the Company for services rendered under a September 16, 2016 Support Services Agreement with the Company during the three months ended March 31, 2017. b) Nathan Hawkins, a director of the Company, has an indirect 47.5% interest in Physicians Stat Lab LLC, a medical services laboratory. In connection with support services rendered by the Company, Physicians Stat Lab, LLC made $139,311 of consulting payments to Lifestyle during the three months ended March 31, 2017.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2017
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	8. COMMITMENTS AND CONTINGENCIES Consulting Agreements a) Lifestyle entered into various consulting agreements with third parties in connection with business advisory services and management support services. For the three months ended March 31, 2017 and 2016, consulting services amounted to $1,024,200 and $74,050, respectively. b) Lifestyle entered into an employment agreement with Christopher Smith ("Smith"), the Company's Chief Executive Officer. The term of the agreement is for five years. Effective August 1, 2015, the monthly salary for Smith was increased to $12,500. Smith will also receive a performance bonus based on a percentage of the Company's net operating profit before income taxes. For the three months ended March 31, 2017, and 2016, payroll-officer amounted to $37,500 and $37,500, respectively.

Revision of Prior Quarters Fina

Revision of Prior Quarters Financial Statement	3 Months Ended
	Mar. 31, 2017
Revision of Prior Quarters Financial Statement [Abstract]
REVISION OF PRIOR QUARTERS FINANCIAL STATEMENT	9. REVISION OF PRIOR QUARTERS FINANCIAL STATEMENT During the audit of the Company’s financial statements for the year ended December 31, 2016, the Company identified an error relating to the recognition of income. The effect of error is to increase net loss for the period ended March 31, 2016. In accordance with the guidance provided by the SEC’s Staff Accounting Bulletin 99, Materiality, and Staff Accounting Bulletin No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Measurements in Current Year Financial Statements, the Company determined that the impact of the adjustments relating to the correction of this accounting error are not material to previously issued unaudited consolidated financial statements. Accordingly, these changes are disclosed herein and will be disclosed prospectively. As a result of the aforementioned correction of accounting errors, the revised prior unaudited financial statements have been revised as follows: Effects on financials for the three months ended March 31, 2016: March 31, 2016 As As Consolidated Balance Sheet Reported Adjustments Revised Accounts Receivable-related party $ 429,337 $ (36,000 ) $ 393,337 Accumulated deficit (9,472,881 ) (36,000 ) (9,508,881 ) Total stockholders' deficit (266,526 ) (36,000 ) (302,526 ) For the Three Months ended As As Consolidated Statement of Operations Reported Adjustments Revised Management fees-related party $ 216,000 $ (36,000 ) $ 180,000 Net loss (111,912 ) (36,000 ) (147,912 ) Net loss-basic and diluted 0.00 0.00 For the Three Months ended As As Consolidated Statement of Cash Flows Reported Adjustments Revised Net loss $ (111,912 ) $ (36,000 ) $ (147,912 ) Accounts receivable 87,531 (36,000 ) 51,531

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2017
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	10. SUBSEQUENT EVENTS In April 2017, the Company issued a convertible note to Roy Meadows and received proceeds of $125,000. The note is convertible into common stock at a conversion price of $0.10 per share. In connection with the convertible note, the Company also issued Meadows a 5-year common stock purchase warrant to purchase 250,000 shares of common stock at an exercise price of $0.16 per share.

Description of Business and S16

Description of Business and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2017
Description of Business and Summary of Significant Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The consolidated financial statements of the Company include the Company and its wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated.
Revenue Recognition	Revenue Recognition The Company records revenue from management fees for providing administrative support and practice management services in accordance with management agreements to other healthcare providers. The Company receives an agreed percentage of the net revenues of these healthcare providers once cash is collected. At this point the services have been rendered, price is determinable and collectability is assured.
Use of Estimates	Use of Estimates The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires the Company to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates including, but not limited to, those related to such items as income tax exposures, accruals, depreciable/useful lives, allowance for doubtful accounts and valuation allowances. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.

Property and Equipment (Tables)

Property and Equipment (Tables)	3 Months Ended
	Mar. 31, 2017
Property and Equipment [Abstract]
Schedule of property and equipment	March 31, December 31, 2017 2016 Equipment $ 124,101 $ 115,887 Accumulated depreciation (53,225 ) (45,985 ) $ 70,876 $ 69,902

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2017
Debt [Abstract]
Summary of short-term debt	March 31, December 31, 2017 2016 Short-term and Convertible Debt Unsecured promissory note, interest 12% per annum, due July 15, 2017 $ 150,000 $ 150,000 Unsecured promissory note, interest 10%, due August 15, 2017 75,000 75,000 Convertible promissory note, interest 10% per annum, due November 1, 2017 100,000 100,000 Convertible promissory note, interest 12% per annum, due April 28, 2017 and June 8, 2017 (2) 562,565 461,897 Convertible promissory note, interest 12% per annum, due December 17, 2016 100,000 100,000 Convertible promissory note, interest 10% per annum, due November 1, 2017 50,000 50,000 Unsecured promissory note, interest 10% per annum, due May 1, 2017 25,000 25,000 Secured promissory note, interest 6% per anum due October 15, 2017 (6) 275,000 275,000 Convertible promissory note, interest 12% per annum, due June 13, 2017 (3) 246,685 242,652 Unsecured promissory note, interest free, due on demand (1) - 20,000 Convertible promissory note, interest 12% per annum, due June 13, 2017 (4) 206,874 187,467 Convertible promissory note, interest 12% per annum, due November 28, 2017 (5) 65,802 43,786 Convertible promissory note, interest 12% per annum, due August 24, 2018 (7) 47,512 45,457 1,904,438 1,776,259 Less: Current portion 1,856,926 1,730,802 $ 47,512 $ 45,457 (1) On February 18, 2016, the Company executed an unsecured promissory note with Gail Keats (an unrelated party) and received $30,000. The promissory note is interest-free and is payable on or before August 15, 2016. The Company repaid the note in full in July 2016. In October 2016, Keats advanced an additional $20,000. The note is interest free and due on demand. The Company repaid the note in full in March 2017. (2) On May 16, 2016, the Company amended its loan agreements with Roy Meadows (“Meadows”), an unrelated party. The Company agreed to pay Meadows a renewal fee of $28,000 and $27,956 on its two outstanding loans with Meadows and extend the maturity dates of the loans to April 28, 2017 and June 8, 2017, respectively. The new outstanding balances of the loans including interest and the renewal fees amounted to $308,000 and $307,520, respectively. The Company also agreed to amend the conversion price of the loans into the Company’s common stock to $0.10 per share. At any time, the holder of the notes, at his option, shall have the right to convert the outstanding principal balance or any portion of the principal amount hereof, and any accrued interest into shares of common stock of the Company. The fair value of the common stock at the date of issuance of the advance was $0.13, which created a Beneficial Conversion Feature of $409,766, the beneficial conversion feature was recorded as a debt discount over the life of the notes. The debt discount as of March 31, 2017 was $52,955. (3) On June 13, 2016, the Company issued a convertible promissory note to Meadows and received proceeds of $250,000.The promissory note bears interest 12% per annum and matures one year from the date of issuance. At any time, the holder of the note, at his sole option, shall have the right to convert the outstanding principal amount of this note, or any portion of the principal hereof, and any accrued interest into shares of common stock of the Company, at a conversion price of $0.15 per share. The fair value at the date of issuance was $0.07, which created a beneficial conversion feature of $16,355, the beneficial conversion feature was recorded as a debt discount over the life of the debt. The debt discount as of March 31, 2017 was $3,315. (4) On October 17, 2016, the Company issued a convertible note to Meadows and received proceeds of $250,000. The promissory note bears interest 12% per anum and matures on June 13, 2017. At any time, the holder of the note, at his sole option, shall have the right to convert the outstanding principal amount of this note, or any portion hereof, and any accrued interest into shares of common stock of the Company, at a conversion price of $0.06 per share. The fair value of the common stock at the date of issuance of the advance was $0.07, which created a beneficial conversion feature of $78,705, the beneficial conversion feature was recorded as a debt discount over the life of the note. The debt discount as of March 31, 2017 was $43,126. (5) On November 28, 2016, the Company issued a convertible note to Meadows and received proceeds of $125,000. The promissory note bears interest 12% per anum and matures on November 28, 2017. At any time, the holder of the note, at his sole option, shall have the right to convert the outstanding principal amount of this note, or any portion hereof, and any accrued interest into shares of common stock of the Company, at a conversion price of $0.06 per share. The fair value of the common stock at the date of issuance of the advance was $0.15, which created a beneficial conversion feature of $89,286, the beneficial conversion feature was recorded as a debt discount over the life of the note. The debt discount as of March 31, 2017 was $59,198. (6) On April 1, 2016, the Company issued a secured promissory note to Emile Fares, M.D. (the “Payee”), an unrelated party, and promised to the Payee $275,000 in exchange for all the medical equipment owned by RMC Totalcare Medical PA. The secured promissory note bears interest 6% per anum and matures one year from the date issuance. On April 1, 2017, the Company and payee entered into an agreement to modify the original note of the Company to the payee to decrease the principal amount of the note from $275,000 to $70,000, and to extend the maturity to October 15, 2017. Any interest accrued would be included as part of the principal payment. (7) On August 24, 2016, the Company issued a convertible note to Daniel Hagen, an unrelated party, and received proceeds of $50,000. The promissory note bears interest 10% per anum and matures on August 24, 2018. At any time, the holder of the note, at his sole option, shall have the right to convert the outstanding principal amount of this note, or any portion hereof, and any accrued interest into shares of common stock of the Company, at a conversion price of $0.06 per share. The fair value of the common stock at the date of issuance of the advance was $0.07, which created a beneficial conversion feature of $8,333, the beneficial conversion feature was recorded as a debt discount over the life of the note. The debt discount as of March 31, 2017 was $2,488.

Accounts Payable and Accrued 19

Accounts Payable and Accrued Expenses (Tables)	3 Months Ended
	Mar. 31, 2017
Accounts Payable and Accrued Expenses [Abstract]
Schedule of accounts payable and accrued expenses	March 31, December 31, 2017 2016 Interest $ 228,239 $ 171,636 Salaries – Officer - - Professional fees 111,778 104,278 Consulting 281,263 124,384 Other 12,131 25,921 $ 633,411 $ 426,219 Consulting fee – related Party $ 89,835 $ 71,929

Warrants (Tables)

Warrants (Tables)	3 Months Ended
	Mar. 31, 2017
Warrants [Abstract]
Schedule of changes in warrants outstanding	Shares Price Life Value Outstanding, January 1, 2017 22,834,564 $ 0.10 4.4 Granted 200,000 0.09 5.0 Expired/Cancelled (2,532,446 ) Exercised (927,118 ) 0.025 Outstanding, March 31, 2017 19,575,000 $ 0.09 4.8 years $ 2,769,500 Exercisable, March 31, 2017 19,575,000 $ 0.09 4.8 years $ 2,769,500

Revision of Prior Quarters Fi21

Revision of Prior Quarters Financial Statement (Tables)	3 Months Ended
	Mar. 31, 2017
Revision of Prior Quarters Financial Statement [Abstract]
Schedule of financials information	March 31, 2016 As As Consolidated Balance Sheet Reported Adjustments Revised Accounts Receivable-related party $ 429,337 $ (36,000 ) $ 393,337 Accumulated deficit (9,472,881 ) (36,000 ) (9,508,881 ) Total stockholders' deficit (266,526 ) (36,000 ) (302,526 ) For the Three Months ended As As Consolidated Statement of Operations Reported Adjustments Revised Management fees-related party $ 216,000 $ (36,000 ) $ 180,000 Net loss (111,912 ) (36,000 ) (147,912 ) Net loss-basic and diluted 0.00 0.00 For the Three Months ended As As Consolidated Statement of Cash Flows Reported Adjustments Revised Net loss $ (111,912 ) $ (36,000 ) $ (147,912 ) Accounts receivable 87,531 (36,000 ) 51,531

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Property and Equipment [Abstract]
Equipment	$ 124,101	$ 115,887
Accumulated depreciation	(53,225)	(45,985)
Property and equipment, net	$ 70,876	$ 69,902

Property and Equipment (Detai23

Property and Equipment (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Property and Equipment (Textual)
Depreciation expense	$ 7,240	$ 8,687

Debt (Details)

Debt (Details) - USD ($)		Mar. 31, 2017	Dec. 31, 2016
Short-term Debt [Line Items]
Short-term debt		$ 1,904,438	$ 1,776,259
Less: Current portion		1,856,926	1,730,802
Short-term debt, net		47,512	45,457
Unsecured promissory note, interest @ 12% per annum, due July 15, 2017 [Member]
Short-term Debt [Line Items]
Short-term debt		150,000	150,000
Unsecured promissory note, interest @ 10%, due August 15, 2017 [Member]
Short-term Debt [Line Items]
Short-term debt		75,000	75,000
Convertible promissory note, interest @ 10% per annum, due November 1, 2017 [Member]
Short-term Debt [Line Items]
Short-term debt		100,000	100,000
Convertible promissory note, interest @ 12% per annum, due April 28, 2017 and June 8, 2017 [Member]
Short-term Debt [Line Items]
Short-term debt	[1]	562,565	461,897
Convertible promissory note, interest @ 12% per annum, due December 17, 2016 [Member]
Short-term Debt [Line Items]
Short-term debt		100,000	100,000
Convertible promissory note, interest @ 10% per annum, due November 1, 2017 [Member]
Short-term Debt [Line Items]
Short-term debt		50,000	50,000
Unsecured promissory note, interest @ 10% per annum, due May 1, 2017 [Member]
Short-term Debt [Line Items]
Short-term debt		25,000	25,000
Secured promissory note, interest @ 6% per anum due October 15, 2017 [Member]
Short-term Debt [Line Items]
Short-term debt	[2]	275,000	275,000
Convertible promissory note, interest @ 12% per annum, due June 13, 2017 [Member]
Short-term Debt [Line Items]
Short-term debt	[3]	246,685	242,652
Unsecured promissory note, interest free, due on demand [Member]
Short-term Debt [Line Items]
Short-term debt	[4]		20,000
Convertible promissory note, interest @ 12% per annum, due June 13, 2017 [Member]
Short-term Debt [Line Items]
Short-term debt	[5]	206,874	187,467
Convertible promissory note, interest @ 12% per annum, due November 28, 2017 [Member]
Short-term Debt [Line Items]
Short-term debt	[6]	65,802	43,786
Convertible promissory note, interest @ 12% per annum, due August 24, 2018 [Member]
Short-term Debt [Line Items]
Short-term debt	[7]	$ 47,512	$ 45,457
[1]	On May 16, 2016, the Company amended its loan agreements with Roy Meadows ("Meadows"), an unrelated party. The Company agreed to pay Meadows a renewal fee of $28,000 and $27,956 on its two outstanding loans with Meadows and extend the maturity dates of the loans to April 28, 2017 and June 8, 2017, respectively. The new outstanding balances of the loans including interest and the renewal fees amounted to $308,000 and $307,520, respectively. The Company also agreed to amend the conversion price of the loans into the Company's common stock to $0.10 per share. At any time, the holder of the notes, at his option, shall have the right to convert the outstanding principal balance or any portion of the principal amount hereof, and any accrued interest into shares of common stock of the Company. The fair value of the common stock at the date of issuance of the advance was $0.13, which created a Beneficial Conversion Feature of $409,766, the beneficial conversion feature was recorded as a debt discount over the life of the notes. The debt discount as of March 31, 2017 was $52,955.
[2]	On April 1, 2016, the Company issued a secured promissory note to Emile Fares, M.D. (the "Payee"), an unrelated party, and promised to the Payee $275,000 in exchange for all the medical equipment owned by RMC Totalcare Medical PA. The secured promissory note bears interest @ 6% per anum and matures one year from the date issuance. On April 1, 2017, the Company and payee entered into an agreement to modify the original note of the Company to the payee to decrease the principal amount of the note from $275,000 to $70,000, and to extend the maturity to October 15, 2017. Any interest accrued would be included as part of the principal payment.
[3]	On June 13, 2016, the Company issued a convertible promissory note to Meadows and received proceeds of $250,000.The promissory note bears interest @ 12% per annum and matures one year from the date of issuance. At any time, the holder of the note, at his sole option, shall have the right to convert the outstanding principal amount of this note, or any portion of the principal hereof, and any accrued interest into shares of common stock of the Company, at a conversion price of $0.15 per share. The fair value at the date of issuance was $0.07, which created a beneficial conversion feature of $16,355, the beneficial conversion feature was recorded as a debt discount over the life of the debt. The debt discount as of March 31, 2017 was $3,315.
[4]	On February 18, 2016, the Company executed an unsecured promissory note with Gail Keats (an unrelated party) and received $30,000. The promissory note is interest-free and is payable on or before August 15, 2016. The Company repaid the note in full in July 2016. In October 2016, Keats advanced an additional $20,000. The note is interest free and due on demand. The Company repaid the note in full in March 2017.
[5]	On October 17, 2016, the Company issued a convertible note to Meadows and received proceeds of $250,000. The promissory note bears interest @ 12% per anum and matures on June 13, 2017. At any time, the holder of the note, at his sole option, shall have the right to convert the outstanding principal amount of this note, or any portion hereof, and any accrued interest into shares of common stock of the Company, at a conversion price of $0.06 per share. The fair value of the common stock at the date of issuance of the advance was $0.07, which created a beneficial conversion feature of $78,705, the beneficial conversion feature was recorded as a debt discount over the life of the note. The debt discount as of March 31, 2017 was $43,126.
[6]	On November 28, 2016, the Company issued a convertible note to Meadows and received proceeds of $125,000. The promissory note bears interest @ 12% per anum and matures on November 28, 2017. At any time, the holder of the note, at his sole option, shall have the right to convert the outstanding principal amount of this note, or any portion hereof, and any accrued interest into shares of common stock of the Company, at a conversion price of $0.06 per share. The fair value of the common stock at the date of issuance of the advance was $0.15, which created a beneficial conversion feature of $89,286, the beneficial conversion feature was recorded as a debt discount over the life of the note. The debt discount as of March 31, 2017 was $59,198.
[7]	On August 24, 2016, the Company issued a convertible note to Daniel Hagen, an unrelated party, and received proceeds of $50,000. The promissory note bears interest @ 10% per anum and matures on August 24, 2018. At any time, the holder of the note, at his sole option, shall have the right to convert the outstanding principal amount of this note, or any portion hereof, and any accrued interest into shares of common stock of the Company, at a conversion price of $0.06 per share. The fair value of the common stock at the date of issuance of the advance was $0.07, which created a beneficial conversion feature of $8,333, the beneficial conversion feature was recorded as a debt discount over the life of the note. The debt discount as of March 31, 2017 was $2,488.

Debt (Details Textual)

Debt (Details Textual) - USD ($)	Nov. 28, 2016	Oct. 31, 2016	Oct. 17, 2016	Aug. 24, 2016	Jun. 13, 2016	May 16, 2016	Feb. 18, 2016	Apr. 01, 2017	Mar. 31, 2017	Mar. 31, 2016	Apr. 01, 2016
Debt (Textual)
Debt discount									$ 148,179	$ 57,775
Interest expense									$ 204,782	$ 86,525
Unsecured promissory note, interest @ 12% per annum, due July 15, 2017 [Member]
Debt (Textual)
Debt instrument interest rate									12.00%
Debt instrument, maturity date									Jul. 15, 2017
Unsecured promissory note, interest @ 10%, due August 15, 2017 [Member]
Debt (Textual)
Debt instrument interest rate									10.00%
Debt instrument, maturity date									Aug. 15, 2017
Convertible promissory note, interest @ 10% per annum, due November 1, 2017 [Member]
Debt (Textual)
Debt instrument interest rate									10.00%
Debt instrument, maturity date									Nov. 1, 2017
Convertible promissory note, interest @ 12% per annum, due April 28, 2017 and June 8, 2017 [Member]
Debt (Textual)
Debt instrument interest rate									12.00%
Debt instrument, maturity date									Jun. 8, 2017
Convertible promissory note, interest @ 12% per annum, due April 28, 2017 and June 8, 2017 [Member] | Roy Meadows [Member]
Debt (Textual)
Conversion price						$ 0.10
Fair value of common stock advance per share						$ 0.13
Beneficial conversion feature						$ 409,766
Debt discount									$ 52,955
Convertible promissory note, interest @ 12% per annum, due April 28, 2017 and June 8, 2017 [Member] | Outstanding loan one [Member] | Roy Meadows [Member]
Debt (Textual)
Debt instrument, maturity date						Apr. 28, 2017
Renewal fee amount						$ 28,000
Outstanding loans including interest and renewal fees						$ 308,000
Convertible promissory note, interest @ 12% per annum, due December 17, 2016 [Member]
Debt (Textual)
Debt instrument interest rate									12.00%
Debt instrument, maturity date									Dec. 17, 2016
Convertible promissory note, interest @ 10% per annum, due November 1, 2017 [Member]
Debt (Textual)
Debt instrument interest rate									10.00%
Debt instrument, maturity date									Nov. 1, 2017
Unsecured promissory note, interest @ 10% per annum, due May 1, 2017 [Member]
Debt (Textual)
Debt instrument interest rate									10.00%
Debt instrument, maturity date									May 1, 2017
Secured promissory note, interest @ 6% per anum due October 15, 2017 [Member]
Debt (Textual)
Debt instrument interest rate									6.00%		6.00%
Debt instrument, maturity date									Oct. 15, 2017
Secured promissory note											$ 275,000
Secured promissory note, interest @ 6% per anum due October 15, 2017 [Member] | Subsequent Event [Member]
Debt (Textual)
Debt instrument, maturity date								Oct. 15, 2017
Decrease the principal amount of the note								$ 70,000
Convertible promissory note, interest @ 12% per annum, due June 13, 2017 [Member]
Debt (Textual)
Debt instrument interest rate									12.00%
Debt instrument, maturity date									Jun. 13, 2017
Debt discount									$ 43,126
Convertible promissory note, interest @ 12% per annum, due June 13, 2017 [Member] | Roy Meadows [Member]
Debt (Textual)
Debt instrument interest rate					12.00%
Conversion price					$ 0.15
Fair value of common stock advance per share					$ 0.07
Beneficial conversion feature					$ 16,355
Debt discount									$ 3,315
Proceeds from convertible promissory note					$ 250,000
Debt instrument, term					1 year
Unsecured promissory note, interest free, due on demand [Member]
Debt (Textual)
Debt instrument, maturity date							Aug. 15, 2016
Proceeds from unsecured promissory note							$ 30,000
Additional amount received from Keats		$ 20,000
Convertible promissory note, interest @ 12% per annum, due June 13, 2017 [Member]
Debt (Textual)
Debt instrument interest rate			12.00%						12.00%
Debt instrument, maturity date			Jun. 13, 2017						Jun. 13, 2017
Conversion price			$ 0.06
Fair value of common stock advance per share			$ 0.07
Beneficial conversion feature			$ 78,705
Proceeds from convertible promissory note			$ 250,000
Convertible promissory note, interest @ 12% per annum, due November 28, 2017 [Member]
Debt (Textual)
Debt instrument interest rate									12.00%
Debt instrument, maturity date									Nov. 28, 2017
Convertible promissory note, interest @ 12% per annum, due November 28, 2017 [Member] | Roy Meadows [Member]
Debt (Textual)
Debt instrument interest rate	12.00%
Debt instrument, maturity date	Nov. 28, 2017
Conversion price	$ 0.06
Fair value of common stock advance per share	$ 0.15
Beneficial conversion feature	$ 89,286
Debt discount	59,198
Proceeds from convertible promissory note	$ 125,000
Convertible promissory note, interest @ 12% per annum, due August 24, 2018 [Member]
Debt (Textual)
Debt instrument interest rate									12.00%
Debt instrument, maturity date									Aug. 24, 2018
Convertible promissory note, interest @ 12% per annum, due August 24, 2018 [Member] | Daniel Hagen [Member]
Debt (Textual)
Debt instrument interest rate				10.00%
Debt instrument, maturity date				Aug. 24, 2018
Conversion price				$ 0.06
Fair value of common stock advance per share				$ 0.07
Beneficial conversion feature				$ 8,333
Debt discount									$ 2,488
Proceeds from convertible promissory note				$ 50,000
Convertible promissory note, interest @ 12% per annum, due June 8, 2017 [Member] | Outstanding loan two [Member] | Roy Meadows [Member]
Debt (Textual)
Debt instrument, maturity date						Jun. 8, 2017
Renewal fee amount						$ 27,956
Outstanding loans including interest and renewal fees						$ 307,520

Accounts Payable and Accrued 26

Accounts Payable and Accrued Expenses (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Accounts Payable and Accrued Expenses [Abstract]
Interest	$ 228,239	$ 171,636
Salaries - Officer
Professional fees	111,778	104,278
Consulting	281,263	124,384
Other	12,131	25,921
Accounts payable and accrued expenses, Total	633,411	426,219
Consulting fee - related party	$ 89,835	$ 71,929

Basic and Diluted Earnings Pe27

Basic and Diluted Earnings Per Share (Details)	3 Months Ended
	Mar. 31, 2017shares
Basic and Diluted Earnings Per Share (Textual)
Anti-dilutive potential common shares	36,455,250

Warrants (Details)

Warrants (Details) - Warrants [Member]	3 Months Ended
	Mar. 31, 2017USD ($)$ / sharesshares
Shares
Outstanding, Beginning Balance | shares	22,834,564
Granted | shares	200,000
Expired/Cancelled | shares	(2,532,446)
Exercised | shares	(927,118)
Outstanding, Ending Balance | shares	19,575,000
Exercisable | shares	19,575,000
Exercise Price
Outstanding, Beginning Balance | $ / shares	$ 0.10
Granted | $ / shares	0.09
Expired/Cancelled | $ / shares
Exercised | $ / shares	0.025
Outstanding, Ending Balance | $ / shares	0.09
Exercisable | $ / shares	$ 0.09
Remaining Life
Outstanding, Beginning Balance	4 years 4 months 24 days
Granted	5 years
Outstanding, Ending Balance	4 years 9 months 18 days
Exercisable	4 years 9 months 18 days
Intrinsic Value
Outstanding, Ending Balance | $	$ 2,769,500
Exercisable | $	$ 2,769,500

Warrants (Details Textual)

Warrants (Details Textual) - USD ($)	1 Months Ended	3 Months Ended
	Jan. 31, 2017	Mar. 31, 2017	Feb. 28, 2017
Warrants (Textual)
Fair value of warrants		$ 20,000
Warrants [Member]
Warrants (Textual)
Warrants expired			2,400,000
Fair value of warrants		$ 20,000
Expected term		5 years
Risk free interest rate		1.19%
Dividend yield		0.00%
Volatility		387.10%
Warrants [Member] | Director [Member]
Warrants (Textual)
Issuance of warrant to purchase common stock	200,000
Exercise price	$ 0.09
Warrant expired descirption	These warrants vest immediately and expire 5 years from the date of issuance.
Warrants [Member] | Roy Meadows [Member]
Warrants (Textual)
Issuance of warrant to purchase common stock		927,118

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Related Party Transactions (Textual)
Consulting services -related party	$ 89,835	$ 71,929
Consulting payments	19,984	$ 68,360
Global Physicians Healthcare, Inc [Member]
Related Party Transactions (Textual)
Consulting services -related party	$ 260,297
Christopher Smith [Member]
Related Party Transactions (Textual)
Related party ownership percentage	33.50%
Nathan Hawkins [Member]
Related Party Transactions (Textual)
Related party ownership percentage	33.50%
Consulting payments	$ 139,311
Indirect interest rate percentage	47.50%

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Employment agreement [Member]
Commitments and Contingencies (Textual)
Term of employment agreement	5 years
Effective date	Aug. 1, 2015
Increased monthly salary for smith	$ 12,500
Amount of compensation as per payroll - officer	37,500	$ 37,500
Consulting agreements [Member] | Consulting services [Member]
Commitments and Contingencies (Textual)
Consulting services, amounted	$ 1,024,200	$ 74,050

Revision of Prior Quarters Fi32

Revision of Prior Quarters Financial Statement (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016	Mar. 31, 2016
Consolidated Balance Sheet [Abstract]
Accounts Receivable-related party	$ 19,984	$ 68,360
Accumulated deficit	(12,607,358)	(12,361,758)
Total stockholders deficit	$ (1,604,818)	$ (1,379,218)
As Previously Reported [Member]
Consolidated Balance Sheet [Abstract]
Accounts Receivable-related party			$ 429,337
Accumulated deficit			(9,472,881)
Total stockholders deficit			(266,526)
Adjustments [Member]
Consolidated Balance Sheet [Abstract]
Accounts Receivable-related party			(36,000)
Accumulated deficit			(36,000)
Total stockholders deficit			(36,000)
As Revised [Member]
Consolidated Balance Sheet [Abstract]
Accounts Receivable-related party			393,337
Accumulated deficit			(9,508,881)
Total stockholders deficit			$ (302,526)

Revision of Prior Quarters Fi33

Revision of Prior Quarters Financial Statement (Details 1) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Consolidated Statement of Operations
Management fees-related party	$ 142,611	$ 180,000
Net loss	$ (245,600)	$ (147,912)
Net loss-basic and diluted	$ (0.01)	$ 0
As Previously Reported [Member]
Consolidated Statement of Operations
Management fees-related party		$ 216,000
Net loss		$ (111,912)
Net loss-basic and diluted		$ 0
Adjustments [Member]
Consolidated Statement of Operations
Management fees-related party		$ (36,000)
Net loss		(36,000)
As Revised [Member]
Consolidated Statement of Operations
Management fees-related party		180,000
Net loss		$ (147,912)
Net loss-basic and diluted		$ 0

Revision of Prior Quarters Fi34

Revision of Prior Quarters Financial Statement (Details 2) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Consolidated Statement of Cash Flows
Net loss	$ (245,600)	$ (147,912)
Accounts receivable	$ 228,782
As Previously Reported [Member]
Consolidated Statement of Cash Flows
Net loss		(111,912)
Accounts receivable		87,531
Adjustments [Member]
Consolidated Statement of Cash Flows
Net loss		(36,000)
Accounts receivable		(36,000)
As Revised [Member]
Consolidated Statement of Cash Flows
Net loss		(147,912)
Accounts receivable		$ 51,531

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Events [Member] - Roy Meadows [Member]	1 Months Ended
	Apr. 30, 2017USD ($)$ / sharesshares
Subsequent Events (Textual)
Issuance of warrant to purchase common stock | shares	250,000
Exercise price	$ 0.16
Proceeds from convertible note | $	$ 125,000
Common stock term	5 years
Common stock conversion price	$ 0.10